Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies.

Arias de la Rosa I, Perez-Sanchez C, Ruiz-Limon P, Patiño-Trives A, Torres-Granados C, Jimenez-Gomez Y, Abalos-Aguilera MDC, Cecchi I, Ortega R, Caracuel MA, Calvo-Gutierrez J, Escudero-Contreras A, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N.

Haematologica. 2020 Jan 16. pii: haematol.2018.205047. doi: 10.3324/haematol.2018.205047. [Epub ahead of print]

2.

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis.

Barbarroja N, Arias-de la Rosa I, López-Medina C, Camacho-Sánchez MDR, Gómez-García I, Vélez-García AJ, Escudero-Contreras A, López-Pedrera C, López-Montilla MD, Collantes-Estévez E.

Ther Adv Musculoskelet Dis. 2019 Oct 16;11:1759720X19880742. doi: 10.1177/1759720X19880742. eCollection 2019. No abstract available.

3.

LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients.

Castellví I, Eguiluz S, Escudero-Contreras A, Ríos JJ, Calvo-Alén J, Callejas-Rubio JL, De la Puente C, Simeón CP, Narváez FJ, Espinosa G, Carreira PE, Rubio-Rivas M, Alegre JJ, Guillén-Del-Castillo A, Román-Ivorra JA, Fonollosa V; LAUDES Study Group.

Rheumatol Int. 2019 Nov;39(11):1875-1882. doi: 10.1007/s00296-019-04436-z. Epub 2019 Sep 14.

PMID:
31522232
4.

Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis.

Ruiz-Limon P, Ortega-Castro R, Barbarroja N, Perez-Sanchez C, Jamin C, Patiño-Trives AM, Luque-Tevar M, Ibáñez-Costa A, Perez-Sanchez L, de la Rosa IA, Abalos-Aguilera M, Jimenez-Gomez Y, Calvo-Gutierrez J, Font P, Escudero-Contreras A, Alarcon-Riquelme ME, Collantes-Estevez E, López-Pedrera C; PRECISESADS Clinical Consortium and Flow Cytometry Study Group.

Front Immunol. 2019 May 21;10:1111. doi: 10.3389/fimmu.2019.01111. eCollection 2019.

5.

Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial.

Sanmarti R, Veale DJ, Martin-Mola E, Escudero-Contreras A, González C, Ercole L, Alonso R, Fonseca JE; ToSpace Study Group.

Arthritis Rheumatol. 2019 Oct;71(10):1616-1625. doi: 10.1002/art.40905. Epub 2019 Sep 24.

PMID:
31087542
6.

Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage.

López-Medina C, Garrido-Castro JL, Castro-Jiménez J, González-Navas C, Calvo-Gutiérrez J, Castro-Villegas MC, Ortega-Castro R, Escudero-Contreras A, Font-Ugalde P, Collantes-Estévez E.

Clin Rheumatol. 2018 Jun;37(6):1581-1588. doi: 10.1007/s10067-018-4112-4. Epub 2018 Apr 24.

PMID:
29691772
7.

Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues.

Arias de la Rosa I, Escudero-Contreras A, Rodríguez-Cuenca S, Ruiz-Ponce M, Jiménez-Gómez Y, Ruiz-Limón P, Pérez-Sánchez C, Ábalos-Aguilera MC, Cecchi I, Ortega R, Calvo J, Guzmán-Ruiz R, Malagón MM, Collantes-Estevez E, Vidal-Puig A, López-Pedrera C, Barbarroja N.

J Intern Med. 2018 Jul;284(1):61-77. doi: 10.1111/joim.12743. Epub 2018 Mar 12.

PMID:
29532531
8.

Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients.

Perez-Sanchez C, Font-Ugalde P, Ruiz-Limon P, Lopez-Pedrera C, Castro-Villegas MC, Abalos-Aguilera MC, Barbarroja N, Arias-de la Rosa I, Lopez-Montilla MD, Escudero-Contreras A, Lopez-Medina C, Collantes-Estevez E, Jimenez-Gomez Y.

Hum Mol Genet. 2018 Mar 1;27(5):875-890. doi: 10.1093/hmg/ddy008.

PMID:
29329380
9.

Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.

Cárdenas MJ, de la Fuente S, Castro-Villegas MC, Romero-Gómez M, Ruiz-Vílchez D, Calvo-Gutiérrez J, Escudero-Contreras A, Del Prado JR, Collantes-Estévez E, Font P.

Rheumatol Int. 2017 Oct;37(10):1701-1708. doi: 10.1007/s00296-017-3757-7. Epub 2017 Jun 9.

PMID:
28597307
10.

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.

Ruiz-Limón P, Ortega R, Arias de la Rosa I, Abalos-Aguilera MDC, Perez-Sanchez C, Jimenez-Gomez Y, Peralbo-Santaella E, Font P, Ruiz-Vilches D, Ferrin G, Collantes-Estevez E, Escudero-Contreras A, López-Pedrera C, Barbarroja N.

Transl Res. 2017 May;183:87-103. doi: 10.1016/j.trsl.2016.12.003. Epub 2016 Dec 9.

PMID:
28027930
11.

Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry.

Cárdenas M, de la Fuente S, Castro-Villegas MC, Romero-Gómez M, Ruiz-Vílchez D, Calvo-Gutiérrez J, Escudero-Contreras A, Del Prado JR, Collantes-Estévez E, Font P.

Rheumatol Int. 2016 Dec;36(12):1627-1632. Epub 2016 Oct 24.

PMID:
27778067
12.

Inter-rater reliability of clinical mobility measures in ankylosing spondylitis.

Calvo-Gutiérrez J, Garrido-Castro JL, González-Navas C, Castro-Villegas MC, Ortega-Castro R, López-Medina C, Font-Ugalde P, Escudero-Contreras A, Collantes-Estévez E.

BMC Musculoskelet Disord. 2016 Sep 5;17(1):382. doi: 10.1186/s12891-016-1242-1.

13.

Upswings in Cheerful Mood and Disease Activity in Patients with Rheumatoid Arthritis.

Delgado-Domínguez CJ, Escudero-Contreras A, Font-Ugalde P, Ruiz-Vilchez D, Collantes-Estévez E, Carretero-Dios H.

Int J Behav Med. 2016 Oct;23(5):606-10. doi: 10.1007/s12529-016-9550-2.

PMID:
26917492
14.

Assessment of Fatigue in Spondyloarthritis and Its Association with Disease Activity.

López-Medina C, Schiotis RE, Font-Ugalde P, Castro-Villegas MC, Calvo-Gutiérrez J, Ortega-Castro R, Jiménez-Gasco R, Escudero-Contreras A, Collantes-Estévez E; REGISPONSER Working Group.

J Rheumatol. 2016 Apr;43(4):751-7. doi: 10.3899/jrheum.150832. Epub 2016 Feb 15.

PMID:
26879350
15.

Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry.

Cárdenas M, de la Fuente S, Font P, Castro-Villegas M, Romero-Gómez M, Ruiz-Vílchez D, Calvo-Gutiérez J, Escudero-Contreras A, Casado M, Del Prado J, Collantes-Estévez E.

Rheumatol Int. 2016 Feb;36(2):231-41.

PMID:
26494567
16.

[How to optimize the antiTNF alpha therapy in spondylitis?].

Castro Villegas Mdel C, Escudero Contreras A, Miranda García MD, Collantes Estévez E.

Reumatol Clin. 2012 Mar;8 Suppl 1:S26-31. doi: 10.1016/j.reuma.2012.01.002. Epub 2012 Mar 13. Review. Spanish.

17.

[Efficacy and safety of abatacept in patients with rheumatoid arthritis and no prior treatment with biologics].

Escudero Contreras A, Castro-Villegas MC, Hernández-Hernández MV, Díaz-González F.

Reumatol Clin. 2011 Nov-Dec;7(6):392-6. doi: 10.1016/j.reuma.2011.06.007. Epub 2011 Oct 21. Review. Spanish.

18.

[Chondrocalcinosis and hypomagnesemia: clinical and radiological progression].

González Domínguez J, Escudero Contreras A, Pérez Guijo V, Martínez Sánchez FG, Caracuel Ruiz MÁ, Collantes Estévez E.

Reumatol Clin. 2008 Jan;4(1):37-9. doi: 10.1016/S1699-258X(08)71794-7. Epub 2008 Oct 28. Spanish.

19.

Biological and clinical markers of disease activity in ankylosing spondylitis.

Muñoz-Villanueva MC, Muñoz-Gomariz E, Escudero-Contreras A, Pèrez-Guijo V, Collantes-Estévez E.

J Rheumatol. 2003 Dec;30(12):2729-32. No abstract available.

PMID:
14719229
20.

Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.

Carmo-Pereira S, Bertolaccini ML, Escudero-Contreras A, Khamashta MA, Hughes GR.

Ann Rheum Dis. 2003 Jun;62(6):540-3.

21.

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.

J Rheumatol. 2001 Dec;28(12):2637-43.

PMID:
11764209

Supplemental Content

Loading ...
Support Center